OmegaXL is an over-the-counter joint and muscle supplement made from a green-lipped mussel oil extract, olive oil, and vitamin E. It doesn’t list the amounts of DHA or EPA, the omega-3s usually credited with fish oil’s benefits.
OmegaXLis a branded dietary supplement made from a proprietary lipid extract of New Zealand green-lipped mussels (*Perna canaliculus) plus olive oil and vitamin E.
Each softgel provides 300 mg of the proprietary blend: green-lipped mussel oil extract, extra-virgin olive oil, olive oil, and vitamin E.
The manufacturer recommends 4 softgels daily with food for the first 4–8 weeks, then 2 daily for maintenance.
It is marketed for joint comfort and inflammatory support, but the evidence is modest and not definitive.
Evidence: Consumer Lab found mixed results for joint pain.
The studies were small and funded by the extract’s manufacturer, and one study that compared it to olive oil found no pain reduction.
Marketing: The FDA has warned its distributor in the past over claims that it relieves joint pain.
Allergy caution: The company says its extraction removes allergenic shellfish protein, but people with shellfish allergies should avoid it.
Interactions: Like other omega-3 products, it may matter if you take blood thinners.
Unlike standard fish oil, it is not primarily an EPA/DHA supplement; its proposed active components are marine lipids and specialized pro-resolving mediators (SPMs), though the clinical significance of that distinction in humans remains uncertain.
A 2021 systematic review of nine trials (452 participants) found green-lipped mussel extracts produced a moderate reduction in visual-analog pain scores in osteoarthritis: effect size −0.46
The review concluded there may be benefit for OA pain, but it also noted limitations in study number and quality; larger independent trials are needed.
key PCSO-524 trial compared it with fish oil rather than placebo, limiting how strongly its results can be interpreted.
At least one placebo-controlled trial of a different green-lipped mussel lipid extract found no significant benefit for hip/knee OA pain or function, illustrating mixed results.
Plausible but modest support for symptom relief in knee/hip osteoarthritis; not a substitute for exercise, weight management, PT, NSAIDs/acetaminophen when appropriate, or disease-specific therapy for inflammatory arthritis.
It contains molluscan shellfish oil; although the manufacturer says allergenic proteins are removed, anyone with shellfish allergy should avoid it or use it only with clinician guidance.
Possible adverse effects include GI upset, nausea, diarrhea, headache, and allergic reactions.
As an omega-3-containing marine oil, use caution with anticoagulants/antiplatelets or bleeding risk, particularly at higher intakes; discuss with the prescribing clinician.
It is a supplement, not FDA-approved as a drug; product quality and label claims are not premarket-verified by FDA.
If trying it for osteoarthritis, a reasonable trial is the labeled regimen for about 8 weeks, with a predefined outcome such as pain score, walking tolerance, or NSAID use. If there is no meaningful improvement by 8 weeks, discontinuing is reasonable.
For general cardiovascular omega-3 intake, conventional fish oil with documented EPA/DHA content is usually more straightforward and cost-effective.
OmegaXL’s rationale is specifically joint/inflammatory symptom support rather than delivering high EPA/DHA doses.